Swee-Ling Levea

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND AND OBJECTIVES IL-2 receptor antagonist (IL2-RA) is recommended as a first-line agent for induction therapy in renal transplantation. However, this remains controversial in deceased donor renal transplantation (DDRT) maintained on tacrolimus (TAC)/mycophenolic acid (MPA) with or without steroids. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS We(More)
BACKGROUND The survival benefit from simultaneous liver-kidney transplantation (SLK) over liver transplant alone (LTA) in recipients with moderate renal dysfunction is not well understood. Moreover, the impact of deceased donor organ quality in SLK transplant survival has not been well described in the literature. METHODS The Scientific Registry of(More)
Although dialysis outcomes have improved, kidney transplantation remains the renal replacement modality of choice for eligible individuals. Multiple studies have demonstrated that kidney transplantation is associatedwith improved patient survival comparedwith dialysis. Studies have also demonstrated similar survival benefits in patients with long waiting(More)
  • 1